Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Tilburg, M. A.L.
Right arrow Articles by Surwit, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Tilburg, M. A.L.
Right arrow Articles by Surwit, R. S.
Related Collections
Right arrow Endocrinology
Right arrow Depression
Right arrow Diabetes
Psychosomatic Medicine 63:551-555 (2001)
© 2001 American Psychosomatic Society


ORIGINAL ARTICLES

Depressed Mood Is a Factor in Glycemic Control in Type 1 Diabetes

Miranda A.L. Van Tilburg, PhD, Cynthia C. McCaskill, MSN, James D. Lane, PhD, Christopher L. Edwards, PhD, Angelyn Bethel, MD, Mark N. Feinglos, MD and Richard S. Surwit, PhD

From the Duke University Medical Center, Durham, North Carolina.

Address reprint requests to: Richard S. Surwit, Box 3842, Duke University Medical Center, Durham, NC 27710. Email: Richard.Surwit{at}duke.edu

OBJECTIVE: The diabetes literature contains conflicting evidence on the relationship between depression and glycemic control. This may be due, in part, to the fact that past studies failed to distinguish between patients with type 1 and type 2 diabetes. Because these are actually completely different diseases that are often treated differently and consequently make different demands on patients, the relationship between glycemic control and depressed mood in type 1 and type 2 diabetes was examined separately.

METHODS: The relationship between Beck Depression Inventory (BDI) scores and HbA1c, as an index of long-term glycemic control, was measured in samples of 30 patients with type 1 and 34 patients with type 2 diabetes.

RESULTS: Groups of patients with type 1 and type 2 diabetes did not differ in mean BDI score or HbA1c level. Correlation analysis revealed a significant positive relationship between BDI scores and HbA1c in the type 1 group (r = .44, p < .02) but not in the type 2 group (r = -0.06, p > .05). This relationship was evident throughout the entire range of BDI scores and was not restricted to scores indicative of clinical depression. Patients with type 1 diabetes who had higher HbA1c and BDI scores reported a lower frequency of home blood glucose monitoring.

CONCLUSIONS: Variations in depressive mood, below the level of clinical depression, are associated with meaningful differences in glycemic control in type 1 but not type 2 diabetes. Preliminary data analysis suggests that this effect may be mediated, at least in part, by decreased self-care behaviors in patients with more depressed mood.

Key Words: depression • type 1 diabetes • type 2 diabetes • glycemic control

Abbreviations: HbA1c = hemoglobin A1c; BDI = Beck Depression Inventory; SMBG = self-monitored blood glucose; BMI = body mass index.




This article has been cited by other articles:


Home page
Diabetes CareHome page
M. S. Roy, M. Affouf, and A. Roy
Six-Year Incidence of Proteinuria in Type 1 Diabetic African Americans
Diabetes Care, July 1, 2007; 30(7): 1807 - 1812.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. S. Roy, A. Roy, and M. Affouf
Depression is a Risk Factor for Poor Glycemic Control and Retinopathy in African-Americans With Type 1 Diabetes
Psychosom Med, July 1, 2007; 69(6): 537 - 542.
[Abstract] [Full Text] [PDF]


Home page
J Pediatr PsycholHome page
V. S. Helgeson and S. A. Novak
Illness Centrality and Well-Being Among Male and Female Early Adolescents with Diabetes
J. Pediatr. Psychol., April 1, 2007; 32(3): 260 - 272.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. Georgiades, N. Zucker, K. E. Friedman, C. J. Mosunic, K. Applegate, J. D. Lane, M. N. Feinglos, and R. S. Surwit
Changes in Depressive Symptoms and Glycemic Control in Diabetes Mellitus
Psychosom Med, April 1, 2007; 69(3): 235 - 241.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
P. J. Lustman, R. E. Clouse, B. D. Nix, K. E. Freedland, E. H. Rubin, J. B. McGill, M. M. Williams, A. J. Gelenberg, P. S. Ciechanowski, and I. B. Hirsch
Sertraline for Prevention of Depression Recurrence in Diabetes Mellitus: A Randomized, Double-blind, Placebo-Controlled Trial.
Arch Gen Psychiatry, May 1, 2006; 63(5): 521 - 529.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. E. Egede and D. Zheng
Independent Factors Associated With Major Depressive Disorder in a National Sample of Individuals With Diabetes
Diabetes Care, January 1, 2003; 26(1): 104 - 111.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Psychosomatic Society